NWT’s Chief Public Health Officer is advising the public that two new substances of concern were detected in Yellowknife’s wastewater, isotonitazene and xylazine. This is the first time these substances with known harmful effects have been detected anywhere in the NWT.
The Chief Public Health Officer is urging people who use drugs to take extra precautions. There are no visible warning signs of these substances which cannot be detected by fentanyl test strips. Health officials advise calling 911 or your local health centre if an overdoes is suspected and caution that symptoms of overdose include difficulty walking, talking or staying awake, dizziness and confusion. The Chief Public Health Officer cautioned that Naloxone will not stop the effects of xylazine but should still be used as it will help reverse effects when opioids have been consumed.
The Chief Public Health Officer issued an advisory on July 21 about isotonitazene and xylazine, the two substances of concern.
Both drugs were identified in the most recent National Wastewater Drug Surveillance report that tested samples from a Yellowknife site from May 2025.
The Chief Public Health Office noted this is the first time these substances have been detected anywhere in the NWT.
Isotonitazene and xylazine, the two substances of concern, both have the potential to cause harmful effects in humans based on potency, said the Chief Public Health Officer.
The wastewater report also showed that fentanyl analogue, which are synthetic opioids structurally related to fentanyl and have similar effects, were also present at detectable levels. This was the only the second time fentanyl analogue has been detected in N.W.T. wastewater since monitoring first began in July 2024.
Isotonitazene is a synthetic opioid that acts similarly to fentanyl. Isotonitazene is believed to be generally more potent than fentanyl, but health officials said the data to confirm that is limited.
The Chief Public Health Officer advised that isotonitazene overdose can be reversed with Naloxone.
Isotonitazene is part of the drug family called nitazenes, first found in Canada’s unregulated drug supply in 2019.
Nitazenes are chemically distinct from fentanyl and cannot be detected with a fentanyl test strip, said health officials.
“Nitazenes were first synthesized in the 1950s as research chemicals, but have never been adopted for clinical use due to unpredictable pharmacokinetics and the availability of safer alternatives. They have been increasingly detected in Canada since 2024. In April 2025, RCMP in Fort Saint John, BC, reported three deaths attributed to counterfeit “Oxycet” tablets laced with isotonitazene,” said health officials.
Xylazine is described as a potent sedative which has been used to alter illegal opioids, including fentanyl. It is classified as something called “an α2-adrenergic agonist,” so it is not an opioid. The Chief Public Health Officer cautioned that this means that naloxone cannot directly reverse its effects. Health officials also warned that this drug also cannot be detected by a fentanyl test strip.
The drug is normally used as a tranquilizer in veterinary treatments. Since 2024, clusters of cases of overdose across Canada have been reported due to this drug
since early 2024 have been attributed to xylazine mixed with fentanyl.
The Chief Public Health Officer warns that there are no visible warning signs that street drugs contain nitazenes or xylazine. These drugs cannot be detected by sight, smell, or taste.
“Importantly, these drugs cannot be detected by fentanyl test strips,” warned health officials. Because the drugs cannot be detected through the tests strips, it is important to note that a negative test does not mean drugs tested are safe.
Health officials warned that because isotonitazene is an opioid, an overdose will look the same as one caused by fentanyl or other opioids.
“There is no way to differentiate nitazene poisoning from any other opioid without advanced testing,” said officials.
The Chief Public Health officer warned that xylazine typically worsens opioid overdose and will also present similarly to a normal overdose. Some unique features of overdoses involving xylazine include:
Naloxone may be less effective, and sedation may persist even if breathing is restored
Possibility of severe skin ulcers at the site of injection
What to do if you suspect an overdose
The Chief Public Health officer advised that anyone who suspects overdose, should call 911 or their local health centre.
- Health authorities warned that signs and symptoms of opioid overdose can include the following:
- difficulty walking, talking or staying awake
- dizziness and confusion
- very small pupils
- unresponsiveness (unable to wake up, even when shaken or shouted at)
- signs of hypoxia
- slow, weak or no breathing
- blue, purple or grey lips or nails
- cold and clammy skin
- choking, gurgling or snoring sounds
Health officials advised that Naloxone should be used in the presence of xylazine mixed with opioids. While it will not stop effects of xylazine, it will reverse the effects when opioids are also consumed. Health officials advised it is important to know that xylazine may cause sedation that will last even after naloxone has restored normal breathing. Officials advised that additional doses may not be required but emergency responders should still be contacted for assistance.
The Chief Public Health Officer cautioned that it is not possible to know how these drugs might appear on the street from the information gathered from wastewater.
Anyone who would like more information is advised to visit GNWT’s Opioid prevention webpages




